152 related articles for article (PubMed ID: 27879294)
1. CXCR2 is involved in pulmonary intravascular macrophage accumulation and angiogenesis in a rat model of hepatopulmonary syndrome.
Li X; Chen Y; Chang Y; Li S; Zhao Z; Zhang H
Clin Sci (Lond); 2017 Jan; 131(2):159-168. PubMed ID: 27879294
[TBL] [Abstract][Full Text] [Related]
2. TNF-α neutralization improves experimental hepatopulmonary syndrome in rats.
Liu L; Liu N; Zhao Z; Liu J; Feng Y; Jiang H; Han D
Liver Int; 2012 Jul; 32(6):1018-26. PubMed ID: 22672643
[TBL] [Abstract][Full Text] [Related]
3. Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling.
Zhu J; Qiu J; Chen K; Wang W; Zheng S
Biomed Pharmacother; 2021 May; 137():111263. PubMed ID: 33516071
[TBL] [Abstract][Full Text] [Related]
4. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB
J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346
[TBL] [Abstract][Full Text] [Related]
5. Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury.
Chen B; Ning JL; Gu JT; Cui J; Yang Y; Wang Z; Zeng J; Yi B; Lu KZ
Liver Int; 2015 Apr; 35(4):1373-82. PubMed ID: 25113058
[TBL] [Abstract][Full Text] [Related]
6. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
Yang W; Zhang J; Hu B; Wu W; Venter J; Alpini G; Fallon MB
Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G72-80. PubMed ID: 24200956
[TBL] [Abstract][Full Text] [Related]
7. AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs.
Shen CC; Chen B; Gu JT; Ning JL; Zeng J; Yi B; Lu KZ
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):676-684. PubMed ID: 29233725
[TBL] [Abstract][Full Text] [Related]
8. Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
Li X; Chen Y; Wang L; Shang G; Zhang C; Zhao Z; Zhang H; Liu A
Braz J Med Biol Res; 2016 Jul; 49(7):. PubMed ID: 27383124
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
Zhang J; Luo B; Tang L; Wang Y; Stockard CR; Kadish I; Van Groen T; Grizzle WE; Ponnazhagan S; Fallon MB
Gastroenterology; 2009 Mar; 136(3):1070-80. PubMed ID: 19109954
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung.
Chang CC; Wang SS; Hsieh HG; Lee WS; Chuang CL; Lin HC; Lee FY; Lee SD; Huang HC
Clin Sci (Lond); 2015 Sep; 129(6):449-60. PubMed ID: 25940601
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 promotes pulmonary intravascular macrophage accumulation by exacerbating BMP signaling in rat experimental hepatopulmonary syndrome.
Liu C; Gao J; Chen B; Chen L; Belguise K; Yu W; Lu K; Wang X; Yi B
Biochem Pharmacol; 2017 Aug; 138():205-215. PubMed ID: 28642034
[TBL] [Abstract][Full Text] [Related]
12. Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice.
Raevens S; Geerts A; Paridaens A; Lefere S; Verhelst X; Hoorens A; Van Dorpe J; Maes T; Bracke KR; Casteleyn C; Jonckx B; Horvatits T; Fuhrmann V; Van Vlierberghe H; Van Steenkiste C; Devisscher L; Colle I
Hepatology; 2018 Aug; 68(2):634-651. PubMed ID: 29023811
[TBL] [Abstract][Full Text] [Related]
13. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats.
Luo B; Liu L; Tang L; Zhang J; Ling Y; Fallon MB
Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G294-303. PubMed ID: 14715521
[TBL] [Abstract][Full Text] [Related]
14. Role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome.
Wu W; Zhang J; Yang W; Hu B; Fallon MB
J Gastroenterol Hepatol; 2016 Nov; 31(11):1888-1894. PubMed ID: 27029414
[TBL] [Abstract][Full Text] [Related]
15. M2 macrophage accumulation contributes to pulmonary fibrosis, vascular dilatation, and hypoxemia in rat hepatopulmonary syndrome.
Chen B; Yang Y; Yang C; Duan J; Chen L; Lu K; Yi B; Chen Y; Xu D; Huang H
J Cell Physiol; 2021 Nov; 236(11):7682-7697. PubMed ID: 34041750
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanism of tumor necrosis factor-alpha monoclonal antibody in hepatopulmonary syndrome in rats].
Huang X; Liu LI; Liu N
Zhonghua Gan Zang Bing Za Zhi; 2015 Jun; 23(6):458-63. PubMed ID: 26236934
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis.
Chang CC; Chuang CL; Lee FY; Wang SS; Lin HC; Huang HC; Teng TH; Hsu SJ; Hsieh HG; Lee SD
Clin Sci (Lond); 2013 Apr; 124(7):457-66. PubMed ID: 23043394
[TBL] [Abstract][Full Text] [Related]
18. CX3CR1 participates in pulmonary angiogenesis in experimental hepatopulmonary syndrome mice through inhibiting AKT/ERK signaling pathway and regulating NO/NOS release.
Gu HJ; Zuo S; Liu HY; Gu LL; Yang XW; Liao J; Wang QQ; Zhao R; Feng XS; Li HY
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6645-6656. PubMed ID: 31378907
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic related functions of bone marrow mesenchymal stem cells are promoted by CBDL rat serum via the Akt/Nrf2 pathway.
Shen CC; Chen B; Gu JT; Ning JL; Chen L; Zeng J; Yi B; Lu KZ
Exp Cell Res; 2016 May; 344(1):86-94. PubMed ID: 27105936
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline attenuation of experimental hepatopulmonary syndrome.
Zhang J; Ling Y; Tang L; Luo B; Chacko BK; Patel RP; Fallon MB
J Appl Physiol (1985); 2007 Mar; 102(3):949-55. PubMed ID: 17110505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
